Podcasts about American Academy

This Flashback Friday and 10th show is from episode 340, published last Sep 25, 2013. Renowned author, physiologist, evolutionary biologist and bio geographer, Dr. Jared Diamond, joins Jason Hartman for a discussion of his newest book, The World Until Yesterday. Dr. Diamond's unique background has shaped his integrated version of human history. He posits that success – and failure – depends on how well societies adapt to their changing environment. Dr. Diamond is also a medical researcher and professor of physiology at the UCLA School of Medicine. His book "Guns, Germs and Steel" won a Pulitzer Prize and "The Third Chimpanzee" was a best-selling award winner. Elected to the American Academy of Arts and Sciences, the National Academy of Sciences and the American Philosophical Society, Professor Diamond is a MacArthur Fellow who has published over 200 articles in Discover, Natural History, Nature and Geo magazines. In his books Guns, Germs and Steel and Collapse (and the popular PBS and National Geographic documentaries they inspired), big-picture scholar Jared Diamond explores civilizations and why they all seem to fall. Now in his latest book, The World Until Yesterday, Diamond examines the traditional societies of New Guinea -- and discovers that modern civilization is only our latest solution to survival.     Follow Jason on TWITTER, INSTAGRAM & LINKEDIN Twitter.com/JasonHartmanROI Instagram.com/jasonhartman1/ Linkedin.com/in/jasonhartmaninvestor/ Call our Investment Counselors at: 1-800-HARTMAN (US) or visit: https://www.jasonhartman.com/ Free Class:  Easily get up to $250,000 in funding for real estate, business or anything else: http://JasonHartman.com/Fund CYA Protect Your Assets, Save Taxes & Estate Planning: http://JasonHartman.com/Protect Get wholesale real estate deals for investment or build a great business – Free Course: https://www.jasonhartman.com/deals Special Offer from Ron LeGrand: https://JasonHartman.com/Ron Free Mini-Book on Pandemic Investing: https://www.PandemicInvesting.com  

Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 700 awesome, curious, kind, funny, brilliant, generous souls Karen Elliott House is a senior fellow at Harvard Kennedy School's Belfer Center for Science and International Affairs. Elliott House retired in 2006 as publisher of The Wall Street Journal, senior vice president of Dow Jones & Company, and a member of the company's executive committee.  She is a broadly experienced business executive with particular expertise and experience in international affairs stemming from a distinguished career as a Pulitzer Prize winning reporter and editor. She is author of On Saudi Arabia: Its People, Past, Religion, Fault Lines—and Future, published in September 2012 by Knopf. During a 32-year career with Dow Jones and The Wall Street Journal, Elliott House also served as foreign editor, diplomatic correspondent, and energy correspondent based in Washington D.C.  Her journalism awards include a Pulitzer Prize for international reporting for coverage of the Middle East (1984), two Overseas Press Club awards for coverage of the Middle East and of Islam and the Edwin M. Hood award for Excellence in Diplomatic Reporting for a series on Saudi Arabia (1982). In both her news and business roles, she traveled widely over many years and interviewed world leaders including Saddam Hussein, Lee Kwan Yew,  Zhu Rongji, Vladimir Putin, Shimon Peres, Benjamin Natanyahu, Saudi King Abdullah, Hosni Mubarak, Margaret Thatcher, Richard Nixon, Helmut Kohl, George H.W. Bush, the late King Hussein and Yasser Arafat. She  has appeared frequently on television over the past three decades as an executive of the Wall Street Journal and as an expert on international relations. Elliott House has served and continues to serve on multiple non-profit boards including the Rand Corp., where she is chairman of the board, the Trilateral Commission, the Council on Foreign Relations, the Asia Society, the German-American Council, and Boston University.  She also is a member of the advisory board of the College of Communication at the University of Texas. She is a graduate of the University of Texas at Austin where in 1996 she was the recipient of the University's “Distinguished Alumnus” award.  She studied and taught at Harvard University's Institute of Politics and she holds honorary degrees from Pepperdine University (2013), Boston University (2003) and Lafayette College (1992).  She also is a fellow of the American Academy of Arts and Sciences.

Today, we're continuing our exploration of the fascinating intersection between positive psychology and travel and I couldn't be more excited to have one of the leading minds in the field with us.  Shige Oishi is a Professor of Psychology at the University of Chicago, an elected member of the American Academy of Arts and Sciences, and one of the most cited psychologists in the world. With over 200 journal articles and books to his name — including his latest book, Life in Three Dimensions — Shige has spent decades researching happiness, meaning, and cultural influences on well-being. In today's episode, we unpack what psychological richness really means, how it differs from happiness and meaning, and how travel is one of the very best ways tap into this powerful dimension of life.  If you've ever felt that travel enriches your life in unexpected ways, this episode is for you. So sit back, relax, and get ready to dive into the world of curiosity and perspective shifts with one of the foremost experts on the subject.  Let's dive in!  Learn more at www.luxtravelinsider.com   Connect with me on Social: Instagram LinkedIn  

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 2 The discussion covered the following topics: Rusk's interprofessional approach to patient care, future hiring needs, health promotion efforts to enhance health of staff, preparing Rusk residents for the future in health care, and putting patients first.  

There are few people who have the depth and breadth of knowledge about long-term services and supports than Jennie Chin Hansen, who we are honored to have as the 300th guest on today's episode. With a rich background in nursing and a penchant for solving problems, Hansen's career spans decades of leading top healthcare organizations such as the American Geriatrics Society, AARP, and On Lok, which is the flagship/prototype for what is now known as People for All-Inclusive Care for the Elderly (PACE). She currently serves on the boards of the Medicare Advantage SCAN Health Plan and HelpAge USA. In 2019, she helped to craft the California Masterplan for Aging, now in implementation.  For this week's episode, Hansen sits down with Susan Ryan to discuss how her childhood experience as an Asian girl living in Boston shaped her career choices. She also discusses her desire to see more upstream work that focuses getting “people prepared for their own aging changes.”  Finally, Hansen shares her vision for what she believes will help to not only “hold the line,” but also move it with regard to ensuring economic security for older Americans. Among Hansen's many awards are the American Academy of Nursing's Health Care Leader Award, American Society on Aging's Hall of Fame Award, and the National Council on Aging's Lifetime Achievement Award.  In 2024, she received an honorary Doctorate of Humane Letters degree from Harvard University at its commencement ceremony in May of 2024. Here is video of highlights from that event: https://youtu.be/lzDYU7sNddA?si=W0hGbEWsS8osCaRq. 

In this episode, I'm talking with pediatrician and author Ken Ginsburg about his new book Lighthouse Parenting. Ken shares his powerful framework for showing up as a steady, loving guide for our kids—offering both support and boundaries as they grow. We get into what it means to really know and prepare our kids, how to be their safe harbor in tough times, and why our own self-care matters just as much as theirs, especially in today's world of social media and constant pressure. About Dr. Ken Ginsburg Dr. Ken Ginsburg practices Adolescent Medicine at The Children's Hospital of Philadelphia and is a Professor of Pediatrics at the University of Pennsylvania School of Medicine. Dr. Ginsburg practices social adolescent medicine – service with special attention to prevention and the recognition that social context and stressors affect both physical and emotional health. His research over the last 35 years has focused on facilitating youth to develop their own solutions to social problems and to teach adults how to better serve them. He is the Founding Director of The Center for Parent and Teen Communications which works to empower parents with the skill-sets to strengthen their family connections and position them to guide their teens to become their best selves. It works to shift the cultural narrative about adolescence from being a time to survive to one in which development is to be optimized. His books include, Building Resilience in Children and Teens: Giving Kids Roots and Wings; Congrats- You're Having a Teen!: Strengthen Your Family and Raise a Good Person; and Lighthouse Parenting:Raising your Child with Loving Guidance for an Enduring Bond. All of these works are published by The American Academy of Pediatrics. He currently works with Covenant House International's 35 sites to solidify and magnify their practice model rooted in the healing power of loving and respectful adult connections with youth. Things you'll learn from this episode What “lighthouse parenting” is and how it offers a research-backed framework for guiding kids to grow up as resilient, thriving adults What it means to be a “secure base” for our kids and the power of stability in fostering resilience in all children Why preparing kids for life's challenges starts with feeling unconditionally loved and truly known Why self-care, authentic modeling, and genuine repair are essential for strong parent-child relationships What it means to “actively see the best in our child” and why it matters  Resources mentioned About Dr. Ken Ginsburg Center for Parent and Teen Communication Fostering Resilience Lighthouse Parenting: Raising your Child with Loving Guidance for an Enduring Bond by Dr. Ken Ginsburg Congrats—You're Having a Teen! Strengthen Your Family and Raise a Good Person by Dr. Ken Ginsburg Building Resilience in Children and Teens: Giving Kids Roots and Wings by Dr. Ken Ginsburg Dr. Devorah Heitner on Helping Kids Thrive in a Digital World (Tilt Parenting Podcast) Dr. Devorah Heitner on Parenting Kids Growing Up in Public (Tilt Parenting Podcast) Learn more about your ad choices. Visit podcastchoices.com/adchoices

We're continuing our summer throwback series with a powerful episode that's simply too important to leave behind. While we're taking a short break this summer, we'll be resurfacing some of our most impactful conversations — the ones that made us think, challenged the status quo, and sparked meaningful dialogue. Today's rerun is one of those episodes. Originally aired as Episode 72, this conversation with Jessica Setnick dives headfirst into the controversial 2023 guidelines issued by the American Academy of Pediatrics (AAP). These guidelines made headlines — and not in a good way. Recommending behavioral interventions and even weight loss medications and surgery for children as young as 2, 12, and 13, respectively, the AAP ignited a firestorm of concern within the eating disorder treatment community. Jessica, a fierce advocate and long-time voice in the eating disorder field, joins me to unpack what these guidelines really say, why they're so troubling, and how they reflect a deeper cultural problem rooted in weight stigma. We question authority, untangle complex motivations (hello, pharma profits), and explore what weight-inclusive, ethical pediatric care should actually look like. In this episode, we're talking about: Why the AAP's new guidelines on pediatric weight management are sparking outrage in the eating disorder community. The alarming recommendations to introduce weight loss medications by age 12 and surgery by 13. The pervasive weight stigma built into these guidelines, including the problematic use of BMI as a screening tool. How profit motives, particularly from big pharma, may be influencing the creation of these “medical” guidelines. The real consequences of these interventions: malnutrition, stunted growth, cognitive impacts, and the risk of lifelong eating disorders. The false logic that shrinking a child's body will reduce weight stigma and why that belief is not just wrong, but dangerous. The importance of separating weight from health, and why any medical concerns should be treated based on symptoms, not size. How weight changes can be relevant when viewed contextually, but should never be the sole focus of medical intervention. Why trusting your gut and challenging medical advice is not only okay, but it might be necessary for protecting your child's wellbeing. Where to find weight-inclusive providers and what to ask when choosing a new pediatrician. Tweetable Quotes “Anyone who works in the eating disorder field at all – and probably many humans – knows multiple people, if not themselves, who have had failed weight loss interventions when they were children that then resulted in bigger problems.” – Jessica Setnick “The key is not to just single out the big kids. Any kid with an eating disorder should be evaluated. Any kid with a medical condition should be evaluated.” – Jessica Setnick “Shrinking children does not change their medical conditions.” – Jessica Setnick “‘Does my child have a medical condition, or are you saying my child is too big? Because if it's a medical condition, we'd like to get treatment independent of his size. But if you're saying his size is a problem, that's not a conversation I'm willing to have.'” – Jessica Setnick Resources AAP Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity News release for the AAP new guidelines Understanding Disordered Eating, Ep. 30: Eating Disorders are the Solution Not the Problem with Jessica Setnick, MS, RD, CEDRD-S Jessica on Facebook  Jessica on Instagram  Jessica Setnick: Understanding Nutrition Jessica's Website Grab my Journal Prompts Here! Looking for a speaker for an upcoming event? Let's chat! Accepting new clients in July - Find out if we're a good fit!   LEAVE A REVIEW + help someone who may need this podcast by sharing this episode. Be sure to sign up for my weekly newsletter here You can connect with me on Instagram @rachelleheinemann, through my website www.rachelleheinemann.com, or email me directly at rachelle@rachelleheinemann.com

In this solo episode, Dr. Joy Kong breaks down the 5 biggest mistakes patients make when undergoing stem cell therapy—and how to avoid them to get the most out of your investment. Learn why using your own cells may not be ideal, the dangers of over-expanded lab-grown cells (especially from overseas clinics), and how lifestyle habits like overexertion, alcohol, and poor diet can sabotage your results. If you're considering regenerative therapy, this is essential listening for safer, more effective outcomes.Additional Resources:Visit My Clinic: Chara Health

In Part 2 of our discussion on Homer's Iliad, translator Emily Wilson returns to discuss the red and gold cover design of the Norton Library edition, recount her decision to recreate a new translation of the epic, and give a performance in the original ancient Greek. Emily Wilson is a professor of classical studies at the University of Pennsylvania. She has been named a Fellow of the American Academy in Rome in Renaissance and early modern studies, a MacArthur Fellow, and a Guggenheim Fellow. In addition to Homer's Iliad and Odyssey, she has also published translations of Sophocles, Euripides, and Seneca. She lives in Philadelphia.To learn more or purchase a copy of the Norton Library edition of The Iliad, go to https://wwnorton.com/books/9781324102076. Learn more about the Norton Library series at https://wwnorton.com/norton-library.Have questions or suggestions for the podcast? Email us at nortonlibrary@wwnorton.com or find us on Twitter at @TNL_WWN and Bluesky at @nortonlibrary.bsky.social. 

Join Elevated GP: www.theelevatedgp.com Net32.com  Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram As the founder and director of Spear Education, Dr. Spear continues to be recognized as one of the premier educators in esthetic and restorative dentistry in the world today. Dr. Spear earned his dental degree from the University of Washington in 1979, and an MSD in periodontal prosthodontics in 1982, also from the University of Washington. Dr. Spear has been recognized by numerous associations for his contributions to dentistry. In 1993, he was awarded the Christensen Award for Excellence in Restorative Education from the Chicago Dental Society. In 1995, the American Academy of Cosmetic Dentistry presented him with a special award for having advanced the Art and Science of cosmetic dentistry in the United States. In 1996, he received the Saul Schluger Memorial Award for Excellence in Diagnosis and Treatment Planning from the Seattle Study Club. In 2003 he and colleague Vincent G. Kokich were awarded the first ever Presidents Award for excellence in education from the American Academy of Esthetic Dentistry. He also earned the 2004 Distinguished Alumnus Award from Pacific Lutheran University his undergraduate Alma Mater. And in 2013 was named Distinguished Alumnus for the University of Washington School of Dentistry. In 2018 he received the first ever Charles Pincus - Ronald Goldstein Lifetime Achievement Award in Esthetic Dentistry from the American Academy of Esthetic Dentistry. He belongs to multiple dental organizations including the American Academy of Esthetic Dentistry, American Academy of Restorative Dentistry, and the American College of Prosthodontics.

Dr. Clayton Moss, MD is a Physical Medicine & Rehabilitation (PM&R) physician currently completing his residency at the University of South Florida. He's also pursuing advanced training in functional, regenerative, and metabolic medicine through the American Academy of Anti-Aging Medicine (A4M). Clayton's mission is to help patients reclaim their health by getting to the root cause. He's an advocate for lifestyle changes and strength training as medicine, and has helped pilot the VA's first inpatient metabolic rehabilitation program. He believes the future of medicine is personal, preventative, and performance-focused — and he's building his career around that belief. Instagram: https://www.instagram.com/drclaymoss/ Timestamps: 00:00 Trailer 00:42 Introduction 03:07 Comprehensive rehabilitation medicine 07:11 Seeking deeper medical learning 09:30 Medical field mental vs. physical load 15:35 Effective physical exam and body composition 17:43 Optimal lean mass and body fat 20:18 Preventing hip fractures & metabolic syndrome 23:48 Carnivore diet as a tool 28:50 Medical profession and social media 30:20 Restoring the art of medicine 35:31 Wellness through mindful living 37:28 Where to find Clay Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

In this episode of Talking Sleep, Drs. Michelle Cantwell and Aaron Glick discuss the updated American Academy of Dental Sleep Medicine (AADSM) Standards for Practice. Dr. Michelle Cantwell received her DMD through the University of Pittsburgh's School of Dental Medicine, where she also completed a three-year residency in prosthodontics. Following dental school, she served as a lieutenant commander in the US Navy. She is a diplomate of the ABDSM and the president-elect of the AADSM. She works in the pulmonary and sleep medicine department of WellSpan Health. Aaron Glick, DDS, FAGD, FICOI, D.ABDSM, is a dentist who has committed his practice to dental sleep medicine. He has been recognized as a “Top 10 Dentist to Watch” and works clinically utilizing teledentistry for efficient patient care. Dr. Glick educates fellow practitioners as the Mastery Program Director at the American Academy of Dental Sleep Medicine, focusing on mandibular advancement devices. Additionally, he is on the faculty at the University of Texas Health Science Center at Houston School of Dentistry. He actively lectures nationally and publishes on obstructive sleep apnea and technology. He enjoys all technologies and has a medical device and software programming background

Join us to hear Jennifer's incredible unexpected journey from mysterious, itchy skin blotches leading to a full psoriasis diagnosis and how she found the right treatment for her with dermatologist Dr. Christina Feser and Mind.Px. Listen as Jennifer tells her diagnostic odyssey from itchy, skin blotches to psoriasis with host Max Blitstein as together they explore her journey from topical treatments to biologics, and the emotional toll this disease can take. Learn how this psoriasis patient found relief with Dr. Christina Feser through the use of new precision medicine technology to find the right treatment for her. This episode highlights the importance of proactive care and the life-changing impact of finding the right medical support. Timestamps: ·       (0:00)  Intro to Psound Bytes™ and guest welcome dermatologist Dr. Christina Feser and her patient Jennifer Kirsch. ·       (1:26)  Jennifer's life prior to her diagnosis journey with psoriasis. ·       (2:29)  Symptoms, diagnosis, and initial treatment course. ·       (4:26)  The path to taking control of Jennifer's psoriasis begins with a Mind.Px test. ·       (9:15)  Timeline for the Mind.Px test results and how it felt to get the test. ·       (12:14) Implementation and results of the treatment recommended by Dr. Feser and the Mind.Px test. ·       (17:22) The emotional impact of living with psoriasis.   ·       (19:24) Be proactive when something is not right. Listen to your body. ·       (19:57) Getting on the right medicine initially has value.  ·       (21:16) While the journey is not easy, taking advantage of available technology offers better management of patients with psoriasis. 3 Key Takeaways: ·       Diagnosis of psoriasis can be challenging but it all starts with finding the right health care provider who listens to you as a patient.   ·       Technology now exists through Mind.Px to help providers and patients select a therapy that is more biologically appropriate to manage their psoriasis. ·       Be proactive in taking steps to ensure you receive the right treatment for you and your health. Guest Bios:   Dr. Christina Feser is a board-certified dermatologist with Nashville Skin, a comprehensive dermatology center for adults and children where she specializes in the latest medical treatments for skin diseases such as psoriasis that impact the skin, scalp, hair, and nails. She has a passion for research, serving as Principal Investigator on numerous clinical trials with a focus on psoriasis, eczema, alopecia, vitiligo, and other skin diseases. She is a fellow of the American Academy of Dermatology, the American Osteopathic College of Dermatology, and is a member of the Nashville Dermatology Society and the Tennessee Dermatology Society. Jennifer Kirsch, a patient of Dr. Feser's, was diagnosed with psoriasis in November 2024 after initially being diagnosed with eczema. Taking matters into her own hands, Jennifer not only found the right care with Dr. Feser, but also the right treatment to help her live her life without the itch associated with psoriasis.  Resources: Ø  Current Biologics on the Market https://www.psoriasis.org/current-biologics-on-the-market/ Ø  Mindera Health – Shaping the Era of Digital Predictive Skin Analytics       https://minderahealth.com

On this episode of Newly Erupted, host Dr. Joel Berg talks about the keys to avoiding burnout with Dr. Trudy-Ann Frazer. Dr. Frazer shares her three-step approach to mitigating burnout, particularly for female practitioners and what steps to take once you realize burnout has taken hold – either in yourself or your team. Guest Bio: Dr. Trudy-Ann Frazer has experience working exclusively with children. It is her goal to promote good oral habits to children and parents as a part of preserving beautiful, healthy smiles for a lifetime. She earned her DDS from Meharry Medical College in Nashville, Tennessee as the Valedictorian, then completed her certificate in Pediatric Dentistry residency from the Albert Einstein College of Medicine/ Montefiore Medical Center in the Bronx, New York. She is a proud graduate of Oakwood University in Huntsville, Alabama where she received her Bachelor of Science in Biology. Dr. Frazer was born in Negril, Jamaica and grew up in Stone Mountain, Georgia. She has dedicated much of her professional career to educating and serving children and participated in numerous outreach activities, which include several mission trips to offer dental services to children in Jamaica. She is also involved in various organizations, including the American Academy of Pediatric Dentistry, American Dental Association, and National Dental Association, as well as a diplomate of the American Board of Pediatric Dentistry. She enjoys swimming, basketball, camping, traveling and spending quality time with her family and friends.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Robert Whitfield speaks with Dr. Laura Miles about her own journey and how she transitioned from ophthalmology to functional medicine after facing health challenges linked to her breast implants following breast cancer. She talks about the complicated nature of breast implant illness, touching on things like infections, heavy metal toxicity, and autoimmune reactions. The conversation dives into why it's so important to thoroughly evaluate each patient, consider genetic testing, and raise more awareness about the potential complications of implants. Dr. Miles effectively highlights the need for personalized care, ongoing research, and advocacy for patient safety, sharing valuable insights for both patients and practitioners dealing with these challenging health issues. Tune in to hear more! Bio: Dr. Laura Miles Dr. Laura Miles graduated with honors from the University of Oklahoma College of Medicine. She was a member of Phi Beta Kappa and Alpha Omega Alpha Honor Societies in undergraduate and medical school, respectively. She completed her internship and residency through the University of Oklahoma Health Sciences Center. Originally board-certified in Ophthalmology, Dr. Miles' personal journey toward healthy living has led her to train with the Anti-Aging and Regenerative Medical Society. This special training has resulted in yet another board certification, this one from the American Academy of Anti-Aging Medicine Board. Her diverse background lends itself to a unique approach in managing and maintaining a healthy life. https://lauramilesmd.com/ (https://lauramilesmd.com/), TEDxUCO, (TEDxUCO) Instagram (https://www.instagram.com/lauramilesmd/?hl=en) Show Highlights: Dr. Miles' Health Crisis and Implant Rupture (00:02:36) Details her implant rupture, related symptoms, and subsequent health improvements after removal Heavy Metals and Chelation Success (00:07:02) A case involving heavy metal toxicity (tin) and successful chelation therapy Complexity of Post-Implant Illness (00:07:53) Not all patients recover after implant removal; some require further individualized treatment Genetic Testing and Patient Profiles (00:11:22) Importance of genetic testing in understanding patient susceptibility Lack of Testing on Removed Implants (00:12:10) Dr. Miles notes most surgeons don't test removed implants for contaminants. Testing and Environmental Toxins (00:22:24) Testing for toxins, genetics, and autoimmune issues in patients Holistic Approach to Patient Health (00:31:49) Addressing the whole body, not just the implants Environmental Toxins and Healing Challenges (00:34:22) How environmental toxins like glyphosate and atrazine affect healing Links and Resources Let's Connect Podcast: https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554 Spotify: https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667 TikTok: https://www.tiktok.com/@drrobertwhitfield?t=8oQyjO25X5i&r=1 IG: https://www.instagram.com/breastimplantillnessexpert/ FB: https://www.facebook.com/DrRobertWhitfield Linkedin: https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/ X: https://x.com/rob_whitfieldmd Read this article - https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness Shop: https://drrobssolutions.com SHARP: https://www.harp.health NVISN Labs - https://nvisnlabs.com/ Get access to Dr. Rob's Favorite Products below: Danger Coffee - Use our link for mold free coffee - https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg JASPR Air Purifier - Use code DRROB for the Jaspr Air Purifier - https://jaspr.co/ Echo Water - Get high quality water with our code DRROB10 - https://echowater.com/ BallancerPro - Use code DRROBVIP for the world's leader in lymphatic drainage technology - https://ballancerpro.com Ultrahuman - Use code WHITFIELD10 for the most accurate wearable - https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Odkaz na celý díl⁠V této politické sezóně je více než kdy jindy patrné, že voliči už nevolí podle programu, ale vyhrává metoda „hodím to těmhle, hlavně ať nevládne tamten.” Návrat Čapího hnízda nemá a nebude mít efekt na voliče AB, pomáhá však mobilizovat SPOLU, STAN a Piráty. Druhotně je pak kauza Čapí hnízdo zprávou o rozkladu české justice.Je obvinění Filipa Turka politicky motivované? Jedno trestní oznámení nemusí nic znamenat, on ale jako politicky exponovaná osoba musí unést jeho medializaci. Nečekaně jsme pochválili SPOLU a Piráty a probrali dojmy Majkla Půra z USA.Partnerem podcastu je advokátní kancelář ROWAN LEGAL a provozovatel zdravotnických zařízení PENTA HOSPITALS a American Academy.

In this episode, Adam Biles speaks with acclaimed author Geoff Dyer live from Shakespeare and Company about his new memoir, Homework. Dyer reflects on growing up in 1960s Cheltenham, navigating family, class, and the formation of self. With characteristic wit and insight, he paints portraits of his quietly disappointed mother and parsimonious father, capturing an era that feels remote yet familiar. The conversation explores the power of memory, the weirdness of grammar schools, the ambient presence of war, and the subtle tyranny of the English class system. Dyer discusses how language, books, and music shaped him—and how the past persists in surprising phrases and daily habits. By turns hilarious and moving, this event reminds us why Dyer remains one of the UK's most original and generous literary voices.Buy Homework: https://www.shakespeareandcompany.com/books/homework-3*Geoff Dyer is an award-winning author of four novels and numerous non-fiction books, including Out of Sheer Rage, Yoga for People Who Can't Be Bothered to Do It, Zona and, most recently, See/Saw. A fellow of the Royal Society of Literature and a member of the American Academy of Arts and Science, Dyer lives in Los Angeles, where he is Writer in Residence at the University of Southern California. His books have been translated into twenty-four languages.Adam Biles is Literary Director at Shakespeare and Company.Listen to Alex Freiman's latest EP, In The Beginning: https://open.spotify.com/album/5iZYPMCUnG7xiCtsFCBlVa?si=h5x3FK1URq6SwH9Kb_SO3w Hosted on Acast. See acast.com/privacy for more information.

In this special episode, recorded on June 24 and released on June 25, we bring you a timely dispatch from Washington, D.C., where the Hospice and Palliative Nurses Association (HPNA) leadership and staff engaged in direct advocacy on Capitol Hill.   Join Gayle Gerdes, Vice President of Health Policy Source and consultant to HPNA, and HPNA Manager of Advocacy and Health Policy Sarah Potter as they reflect on their experiences meeting with congressional staffers about HPNA's public policy priorities and amplifying the voices of hospice and palliative care nurses. This episode offers an insider look at the policy priorities that matter in 2025, from protecting federal programs that support nursing research, education, and workforce development to enactment of policies that improve access to quality hospice and palliative care—and how HPNA is uniquely positioned as an interprofessional voice in the conversation.   Key highlights include:   The purpose and power of advocacy—why storytelling matters   Updates on the current climate in Washington, proposed cuts to healthcare programs that impact the interprofessional team and patient access to care, and HPNA's efforts to advance legislation supporting hospice and palliative care nursing  HPNA's collaborations with national coalition partners and legislative champions in the House and Senate  Reflections on the importance of nurse-led advocacy and new opportunities for HPNA members to share their stories and effect policy change at the state and national levels  Whether you're new to policy or a seasoned advocate, this episode will leave you inspired to raise your voice—and equipped to do so effectively.       Gayle Gerdes  Gayle Gerdes is Vice President at Health Policy Source, a government relations firm in Washington, D.C. that provides strategic consulting and lobbying services to a broad group of clients in the health care space. Her health care background is an extensive mix of government and private sector experience. She spent several years on Capitol Hill where she worked in both the House and the Senate focusing her time on health care legislation. Later she moved to The Concord Coalition where she worked with the media, Members of Congress, and related organizations to educate the public on the federal budget and deficit. In particular, she delved into the relationship of Medicare and Social Security with the federal budget. In addition, Gayle has experience serving on the board of the Los Alamos Medical Center, and she has recently consulted for The Brooks Group and The Concord Coalition. Gayle graduated from the University of Arkansas with a B.A. in English and Communications.    Sarah PotterSarah Potter is the Manager of Advocacy and Health Policy at the Hospice and Palliative Nurses Association (HPNA). Sarah has more than 20 years of experience in government relations, health policy, and communications, with a focus on healthcare workforce issues, Medicare, Medicaid, children's health, quality improvement, and the Affordable Care Act. She has developed and implemented state and federal advocacy campaigns and advocacy education programs for several national organizations, including the Pew Charitable Trusts, Independent Sector, the Premier Healthcare Alliance, and the Brookings Institution. Sarah began her career on Capitol Hill as a legislative and communications staffer for Rep. Karen McCarthy of Missouri and Senator Joe Lieberman of Connecticut and holds dual degrees in Journalism and Political Science from the University of Missouri     Brett Snodgrass, DNP, FNP-C, ACHPN®, FAANP Dr. Brett Snodgrass has been a registered nurse for 28 years and a Family Nurse Practitioner for 18 years, practicing in multiple settings, including family practice, urgent care, emergency departments, administration, chronic pain and palliative medicine. She is currently the Operations Director for Palliative Medicine at Baptist Health Systems in Memphis, TN. She is board certified with the American Academy of Nurse Practitioners. She is also a Fellow of the American Association of Nurse Practitioners and an Advanced Certified Hospice and Palliative Nurse. She completed a Doctorate of Nursing Practice at the University of Alabama – Huntsville. She is a nationally recognized nurse practitioner speaker and teacher. Brett is a chronic pain expert, working for more than 20 years with chronic pain and palliative patients in a variety of settings. She is honored to be the HPNA 2025 podcast host. She is married with two daughters, two son in laws, one grandson, and now an empty nest cat. She and her family are actively involved in their church and she is an avid reader.

Idiopathic intracranial hypertension (IIH), a condition of increased intracranial pressure (ICP), causes debilitating headaches and, in some, visual loss. The visual defects are often in the periphery and not appreciated by the patient until advanced; therefore, monitoring visual function with serial examinations and visual fields is essential. In this episode, Kait Nevel, MD speaks with John J. Chen, MD, PhD, and Susan P. Mollan, MBChB, PhD, FRCOphth, authors of the article “Treatment and Monitoring of Idiopathic Intracranial Hypertension” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Chen is a professor of ophthalmology and neurology at the Mayo Clinic in Rochester, Minnesota. Dr. Mollan is an honorary professor of metabolism and systems science in the department of neuro-ophthalmology at University Hospitals Birmingham in Birmingham, United Kingdom. Additional Resources Read the article: Treatment and Monitoring of Idiopathic Intracranial Hypertension Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Guests: @chenmayo, @DrMollan Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kate Nevel. Today, I'm interviewing Drs John Chen and Susan Mollan about their article on treatment and monitoring of idiopathic intracranial hypertension, which appears in the June 2025 Continuum issue on disorders of CSF dynamics. Drs Chen and Mollan, welcome to the podcast. And please, could you introduce yourselves to the audience? Dr Chen: Hello, everyone. I'm John Chen, one of the neuro-ophthalmologists at the Mayo Clinic. Thanks for having us here. Dr Mollan: Yeah, it's great to be with you here. I'm Susan Mollan. I'm a consultant neuro-ophthalmologist in Birmingham, England. Dr Nevel: Wonderful. So great to have you both here today, and our listeners. To start us off, talking about your article, can you share with us what you think is the most important takeaway from your article for the practicing neurologist out there? Dr Chen: Yeah, so our article talked about the treatment and monitoring of IIH. And I think one takeaway point is, IIH is becoming much more prevalent now that there's this worldwide obesity epidemic with obesity having- essentially being the largest risk factor for IIH other than female. It's really important to monitor vision because vision loss is often peripheral vision loss at first, which the patient may be completely unaware of. And so, it's important to pair up with an ophthalmologist so you can monitor the papilledema of the visual fields and make sure they don't get permanent vision loss. And in the article, we also talk about- there's been changes in the treatment of severe IIH, where traditionally, we used VP shunts; but there's been a trend toward using more venous sinus stenting in addition to the traditional surgeries. Dr Nevel: Great, thank you. I think probably most of our listeners or a lot of neurologists out there have a pretty good understanding of kind of the basics of the IIH. But can you kind of just go over a few key characteristics of IIH, and maybe some things that are less commonly known or things that are maybe just been kind of better understood over the past decade, perhaps? Dr Mollan: Yes, certainly. I think, as Dr Chen said, it's because this condition is becoming more prevalent, people recognize it. I think it's- we like to go back to the diagnostic criteria so that we're making a very accurate diagnosis. So, the patients may come in to the emergency room with, say, papilledema that's been identified elsewhere or crashing headaches. And it's important to go through that sort of diagnostic pathway, taking a blood pressure, taking a full blood count to make sure the patient is anemic, and then moving forward with that confirmation of papilledema into urgent neuroimaging, whether it's CT or MRI, but including venography to exclude a venous sinus thrombosis. And then if you have no structural lesion that's causing the raised ICP, it's moving forward with your lumbar puncture and carefully checking those pressures. But the patients may not only have crashing headache, they often have pulsatile tinnitus and neck pain. I think some of the features that we're now recognizing is the systemic metabolic effects that are unique to IIH. And so, there's an increased risk of cardiometabolic disease that's over and above what is conferred by obesity. Also, our patients have a sort of maternal health burden where they get impaired fertility, gestational diabetes and preeclampsia. And there's also an associated mental health burden, amongst other things. So we're really starting to understand the spectrum of the disease a bit more. Dr Nevel: Yeah, thank you for that. And that really struck me in your article, how important it is to be aware of those things so that we're making sure that we're managing our whole patient and connecting them with the appropriate providers for some of those other issues that may be associated. For the practicing neurologist out there without all the neuro-ophthalmology equipment, if you will, what should our bedside exam focus on to help us get maybe an early but accurate picture of the patient's visual function when we suspect IIH to be at play, perhaps before they can get in with the neuro-ophthalmologist? Dr Chen: Yeah, I think at the bedside you can still check visual acuity and confrontational visual fields, you know, with finger counting. Of course, you have to know that those are, kind of, crude kind of ways of screening. With papilledema, oftentimes the visual acuity is intact. And the confrontational visual fields aren't as sensitive as automated perimetry. Another important thing will be to do your direct ophthalmoscope and look at the amount of papilledema. If it's grade one or two papilledema on the more mild side, it's actually not vision threatening. It's the higher degrees of papilledema that can cause rapid vision loss. And so, if you look in and you see grade one papilledema, obviously you need to do the full workup, the MRI, MRV, lumbar puncture. But in terms of rapidly getting to an ophthalmologist to screen for vision loss, it's not going to be as important because you're not going to have vision loss at that low grade. If you look in and you see this rip-roaring papilledema, grade five papilledema, that patient is going to be at very severe risk of vision loss. So, I think that exam, looking at the optic nerve can be very helpful. And of course, talking to the patient about symptoms; is there decreased vision Is there double vision from a sixth nerve palsy? Are there transient visual obscurations which would indicate at least a higher degree of papilledema? That'd be helpful as well. Dr Nevel: Great, thank you. And when the patient does get in with a neuro-ophthalmologist, you talk in your article and, of course, in clinical practice, how OCT testing is important to monitor in this condition. Can you provide for the listeners the definition of OCT and how it plays a role in monitoring patients with IIH? Dr Mollan: Sure. So, OCT is short for optical coherence tomography imaging, and really the eye has been at the forefront of OCT alone. Our sort of cardiology colleagues are catching up on the imaging of blood vessels. But what it allows us to do is give us really good cross-sectional, anatomical-level changes that we can see both in the retina and also at the optic nerve head. And it gives us some really good measurements. It's not so good at sort of saying, is this definitely papilledema or not? That sort of lower end of disc elevation. But it is very good at ruling out what we call the pseudopapilledema. So, things like drusens or these other little masses we find underneath the optic nerve head. But in terms of monitoring, because we can longitudinally take these images and the reproducibility is pretty good at the optic nerve head, it allows us to see whether there's direct changes: either the papilledema getting worse or the papilledema getting better at the optic nerve head. It also gives us some indication of what's going on in the ganglion cell layer complex. And that can be helpful when we're thinking about sort of looking at structure versus function. So, ophthalmologists in general, we love OCT; and we spend much more time nowadays looking at the OCT than we really do the back of the eye. And it's just become critical for patients with papilledema to be able to be very accurate from visit to visit to see what's changing. Dr Nevel: How do you determine how frequently somebody needs to see the neuro-ophthalmologist with IIH and how often they need that OCT evaluation? Dr Chen: Once the diagnosis of IIH is made, how often they need to be seen and how frequent they need to be seen depends on the degree of papilledema. And again, OCT is really nice. You can quantify it and then different providers can actually use the same OCT numbers, which is super helpful. But again, if it's grade three papilledema or higher, or article thickness of 200 or higher, I tend to follow them a little bit more closely, trying to treat them more aggressively. Try to get the papilledema down into a safer zone. If it's grade one or two papilledema, we see them less frequently. So, my first visit might be three months out. They come with grade five papilledema, I'm seeing them within a few days to make sure that's papilledema's come down quickly because we're trying to decide, are they going to need surgery or not? Dr Nevel: Yeah, great. And that's a nice segue into talking a little bit about how we treat patients with IIH after the diagnosis is confirmed. And I'd like to just point out you have a very lovely figure in your article---Figure 5-6,---that I'd like to direct our listeners to read your article and check out that figure, which is kind of an algorithm on how we think about the various treatment options for patients who have IIH, which seems to rely a lot on the degree of presence of papilledema and the presence of vision disturbance. Could you maybe walk us through a little bit about how you think about the different treatment options for patients with IIH and when more urgent surgical intervention might be indicated? Dr Mollan: Yeah, sure. We always find it quite hard in any medical specialty to write these kind of flow diagrams because it's really an individual we're looking at. But these are kind of what we'd say is “broad brushstrokes” into those patients that we worry about, sort of, red disease in those patients, more amber disease. Now obviously, even those patients that may not have severe papilledema, they may have crashing headaches. So, they may be an urgent referral themselves because of that. And so, it's nice to try and work out which end of the spectrum you're working with. If we think of the papilledema, Dr Chen's already laid out the sort of lower end of the prison's scale---our grades one, our grades two---that we're less anxious about. And those patients, we would definitely be having discussions about medical management, which includes acetazolamide therapy; but also thinking about weight management. And it may well be that we talk a little bit further about weight management, but I think it's helpful to sort of coach those conversations after you've made a definite diagnosis. And then laying out the risk that's caused, potentially, the IIH in an individual. And then having a sort of open conversation with them about what changes they can have in their lifestyle alongside thinking about medical therapy. There's some patients with very low levels of papilledema that we decide not to put on medicines initially. As patients progress up that papilledema grade, we're definitely thinking about medical therapy. And our first line from the IIH treatment trial would be using acetazolamide, but we need to be thinking about using appropriate dosing. So, a lot of the patients that I see can be sent to me with very low doses that may be inappropriate for that person. In the IIHTT they used up to four grams daily in a divided dose. And you do need to counsel your patients when you're putting them on acetazolamide because of the side effects. You've got quite a nice table in this article about the side effects. I think if you get the patient on board, that they understand that they will experience side effects, that is helpful because they will expect it, and then possibly tolerate it a bit better. Moving through to that area where we're more anxious, that visual-threatening papilledema. As Dr Chen said, it's sort of like you look in and it's sort of “blood and thunder” in there. And you need to be getting on and encouraging the ophthalmologist to get a formal assessment of the visual field. It's very difficult to determine exactly the level at which- and we talk about the mean deviation in a lot of our research studies. But in general, it's a combination of things: the patient's journey to get to you, their symptoms, what's going on with the visual field, but what's also happening at the OCT. So, we look in and we see that fluid is seeping towards the fovea. We get very anxious, and those patients may not even have enough time for a rapid escalation of acetazolamide. It may well be at the first presentation, which we would term, like, fulminant; that we'd be thinking about surgical intervention. And I think before I stop, the other thing to say is, the surgical landscape is really changing. So, we're having some good studies coming out in terms of stenting. And so, there is a sort of bracket where it may well be that we are thinking about neuroradiological intervention in an earlier case. They may not quite be at that visual-threatening stage, but they may be resistant to medical treatments. Dr Nevel: Thank you for that. What do you think is a potential pitfall or a mistake to avoid, if you will, in the management of patients with IIH? Dr Chen: I think it's- in terms of pitfalls, I think the potential pitfalls I've seen are essentially patients where we don't necessarily create a good patient physician relationship. Where they don't have buy-ins on the treatment, they don't have buy-ins to come back, and they're lost to follow-up. And these patients can be dangerous, because they could have vision threatening papilledema and if not getting the appropriate treatment---and if they're not monitoring the vision---this can lead to poor outcomes. So, I've definitely seen that happen. As Dr Mollan said, you really have to tell them about the side effects from the medications. If you just take acetazolamide, letting them know the paresthesias and the changes in taste and some of these other side effects, they're going to immediately stop the medication. Again, and these medications do work, proven in the IIH treatment trial. So again, I think that patient-physician relationship is very important to make sure they have appropriate follow up. Dr Nevel: The topic of weight loss in this patient population can be tricky, and I know I talked with Susie in a prior interview about how to approach this topic with our patients in a sensitive and compassionate manner. Once this topic is broached, I find many patients are looking for advice on strategies for weight loss, or potentially medications or other interventions. How do you prioritize or think about the different weight loss strategies or treatments with your patients, and how do you think about the way that you recommend these different treatments or not? Dr Mollan: Yeah. I think that's a really great question because we sort of stray here into a specialty that we have not been trained in. One thing I definitely ask my patients: if they've been on a weight loss journey before, and what's worked for them and what's not worked for them. And within our different healthcare systems, we have access to different tiers of weight management approaches. But for the person sitting in front of me, that possibly there may be a long journey to access more professional care, it's about understanding. iIs there things that are free, such as, we have some apps in the National Health Service which are weight management applications where they can actually just start putting in their calories, their daily calorie intake. And those apps can be quite helpful and guiding in terms of targeting areas, but also informing the patient of what types of foods to avoid in their diet and what types of foods to include in their diet. And with some of the programs that are completely complementary, they also sometimes add on things about exercise. But I think it is a really difficult thing to manage as, say, an ophthalmologist or a neurologist, mainly because it's not our area of expertise. And I think we've all got to find, in our local hospitals and healthcare systems, those pathways where the patients may be able to access nutritional support, and sort of behavioral lifestyle therapy support, all the way through to the new medications for weight loss; and also for some people, bariatric surgery pathways. It's a tricky topic. Dr Nevel: So how should we counsel our patients about what to expect in the future in terms of visual outcomes? Dr Chen: I think a lot of that depends on the degree of papilledema when they present. If a patient comes in with grade five papilledema, that fulminant IIH that Dr Mollan had mentioned, these patients can have very severe vision loss. And even if we treat them very aggressively with high-dose medications and urgent surgical interventions, sometimes they can have permanent vision loss. And so, we counsel them that, you know, there's a strong chance that they're going to have a good amount of vision loss. But some patients, we're very surprised and we get a lot of vision back. So, we kind of set expectations, but we're cautiously optimistic that we can get vision back. If a patient presents with more mild papilledema like grade one or two papilledema, they're most likely not going to have any permanent vision loss as long as we're treating them, we're monitoring their vision, they're coming to their follow-ups. They tend to do very well from a vision perspective. Dr Nevel: That's great, thank you. And you know, ties into what you said earlier about really making sure that, you know, we create good- as with any patient, but good physician-patient relationships so that they, you know, trust us and they come to follow up so we can really monitor their vision appropriately. What do you think is going on in research in this area that's exciting? What do you think one of the next breakthroughs or thing that we need to understand the most about treatment and monitoring of IIH? Dr Chen: I think surgically, venous sinus stenting is going to probably take over the bulk of surgeries. We still need that randomized clinical trial, but we have some amazing outcomes with venous sinus stenting. And there's many efforts on randomized clinical trials for venous sinus stenting. So we'll have those results soon. From a medical standpoint, Dr Mollan can actually say, actually, more about this. Dr Mollan: I completely agree. The GLP-1 receptor agonists, the twofold prong approach: one is the weight loss where these patients, you know, have significant weight loss to put their disease into remission; and the other side of it is whether certain GLP-1s have the ability to reduce intracranial pressure. So, a phase 2 study that we undertook here in Birmingham did show that we were able to reduce intracranial pressure, but we don't think it's a class effect. So, I think the sort of big breakthrough will be looking at novel therapies like xenotide and other drugs that, say, work on the proximal kidney tubule. Are they able to reduce intracranial pressure directly? And I think we are on the cusp of a real breakthrough for this disease. Dr Nevel: Great. Thank you so much for chatting with me today. And I really learned a lot, appreciated the opportunity. I hope our listeners learned something today, too. So again, today I've been interviewing Drs John Chen and Susan Mollan about their article on treatment and monitoring of idiopathic intracranial hypertension, which appears in the most recent issue of Continuum on disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including:The available biologic therapies that specifically target IL-13Where these agents fall in the 2024 American Academy of Dermatology treatment algorithmHow these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitorsA detailed patient case to highlight take home pointsPresenterAndrew F. Alexis, MD, MPH​Professor of Clinical Dermatology​Weill Cornell Medical College ​New York, New YorkDaniel C. Butler, MD​Assistant Dean Student Affairs​University of Arizona College of Medicine – Tucson​Tucson, ArizonaShawn G. Kwatra, MD​Dr. Joseph W. Burnett Endowed Professor and Chair ​Department of Dermatology​University of Maryland School of Medicine​Baltimore, MarylandProgram page:https://bit.ly/4kTP04D

Episode Summary Join Dr. Eric Balcavage and Dr. Kelly Halderman for this milestone 200th episode of Thyroid Answers! This comprehensive discussion covers the evolution of thyroid care, key lessons learned from treating hundreds of patients, and the future of thyroid recovery. Dr. Eric shares his 70% patient recovery rate and explains why the shift from management to recovery is revolutionizing thyroid care. Key Topics & Timestamps

This Week on The Virtual Curbside: Measles Q&A  In this final episode of the measles series, host Paul Wirkus, MD, FAAP, is joined by experts Andy Pavia, MD, and TW Jones, MD, to answer listener questions. The conversation covers practical clinical concerns around measles, including diagnosis, outbreak response, and prevention strategies. The group also dives into broader vaccine topics—discussing the MMR vaccine, mRNA vaccines, and lessons learned from COVID-19. Have a question? Email questions@vcurb.com.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Honorary third host of the podcast Kaylee is back this week to join us in discussing the R.J. Hackett, a vessel that changed the way bulk cargo was transported on the Great Lakes and laid the groundwork for the designs we still see today. gazafunds.comSources: Baker, Newton D. “Transportation on the Great Lakes.” The Annals of the American Academy of Political and Social Science, vol. 171, Jan 1934, pp. 204 - 210. Bowlus, Bruce. “Bold Experiments: The Evolution of the Great Lakes Ore Carrier.” Michigan Historical Review, vol. 22, no. 1, Spring 1996, pp. 1 - 17. “Steamer Hackett Burns.” The Sturgeon Bay Advocate, vol. 44, no. 34, 18 Nov 1905. Support the show

Navigating Pediatric Practice: Insights from Dr. Robert WiskindIn this episode of The Pediatric Lounge podcast, hosts welcome Dr. Robert Wiskind, a seasoned pediatrician with decades of experience in Georgia. Dr. Wiskind shares his journey from medical school at Emory to establishing Peachtree Park Pediatrics and navigating the complexities of independent pediatric practice. The discussion covers the evolution of his practice, from its unique exam room system to growing into a larger facility. Dr. Wiskind emphasizes the value of involving in organized medicine through roles like the Georgia Chapter of the American Academy of Pediatrics, and his contributions to creating the Children's Care Network, a clinically integrated network. Additionally, the episode touches on the challenges and future of independent pediatric practices, the benefits of clinical integration, and the importance of adapting to ongoing changes in medicine. The conversation also delves into balancing patient care with administrative duties, and the collaborative efforts required to sustain and improve pediatric healthcare standards.00:00 Introduction to The Pediatric Lounge00:36 Meet Dr. Robert Wiskiind01:23 Dr. Wiskiind's Journey in Pediatrics03:07 Peachtree Park Pediatrics: A Legacy04:25 The Evolution of the Practice05:12 Partnership Dynamics and Growth08:39 The Children's Care Network13:04 Challenges and Successes in Pediatric Care22:43 The Importance of Organized Medicine29:08 Balancing Parental Expectations and Medical Judgment31:52 Challenges of Setting Up a Collaborative Network32:48 Financial Strategies and Physician Involvement34:49 Future of Independent Practice38:32 Role and Structure of Pediatric Committees43:13 Complexities in Healthcare Policies and Payments48:41 High Costs of Advanced Medical Treatments54:13 Socioeconomic Disparities in Healthcare58:01 Personal Reflections on Career Choices01:00:12 Conclusion and Final ThoughtsSupport the show

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Odkaz na celý díl⁠Apolena Rychlíková a Jakub Zelenka, naše oblíbené duo z druhé strany názorového spektra, se se svým projektem soustředí na on-line svět. V posledních měsících popsali kauzy o praktikách Adama Kajumiho nebo neúspěšnějšího českého tvůrce, který si říká „Mike je pán.” Tradiční média toto prostředí vůbec nechápou, platí zde jiná pravidla, dochází vlastně k digitální odluce státu od společenských fenoménů. Svět pražské mediální scény je pro „normální lidi” úplně irelevantní, shodují se oba hosté.Partnerem podcastu je advokátní kancelář ROWAN LEGAL a provozovatel zdravotnických zařízení PENTA HOSPITALS, American Academy a ARETE Transition Fund pro kvalifikované investory.

Mark Twain didn't just write American classics, he lived one of the most powerful personal transformations in history. In Part 2 of this conversation, Pulitzer Prize-winning biographer Ron Chernow returns to join Ryan for a deep dive into Twain's remarkable moral evolution. They discuss how Twain's journey mirrors those of Ulysses S. Grant and John D. Rockefeller, reflect on the tragic cost of chasing fortune over purpose, and explore what makes a biography timeless and a life unforgettable.Plus, a special moment: Ryan's 8-year-old son jumps in to ask Ron about Hamilton, his favorite musical.Ron Chernow is the prizewinning author of seven previous books and the recipient of the 2015 National Humanities Medal. His first book, The House of Morgan, won the National Book Award, Washington: A Life won the Pulitzer Prize for Biography, and Alexander Hamilton—the inspiration for the Broadway musical—won the George Washington Book Prize. He has twice been a finalist for the National Book Critics Circle Award and is one of only three living biographers to have won the Gold Medal for Biography of the American Academy of Arts and Letters. Ron's latest book is on the fascinating and complex life of American writer Mark Twain. Follow Ron Chernow on Instagram: @RonChernow

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Odkaz na celý díl⁠Polský ústavní soud odmítl klimatické předpisy EU, protože odporují polské ústavě a energetické svrchovanosti země. Je podobný scénář možný i v ČR? Hnutí ANO zvažuje podání stížnosti. Zabrousili jsme do znění smlouvy o fungování EU.Interní průzkum SPOLU překvapivě ukazuje, že BTC pro její voliče není problém. Počkejme však na data, která ukážou volební preference. Vydrží Eva Decroix na MS déle než Táňa Malá? Jaká je nálada uvnitř STAN a Rady ČT?Partnerem podcastu je advokátní kancelář ROWAN LEGAL a provozovatel zdravotnických zařízení PENTA HOSPITALS a American Academy.

Breast cancer is one of the most talked-about health issues in the world, but there's still so much we don't discuss. While mammograms and early detection campaigns have saved countless lives, the conversation often stops there.  What's missing is a deeper look at the lifestyle, genetic, and environmental factors that play a pivotal role in prevention, and the small, daily changes that can make a massive impact. Because here's the truth: 80% of breast cancer cases are not inherited. They're environmental. That means we have far more power than we think. But to tap into it, we need better guidance, smarter screening strategies, and a stronger understanding of how our bodies work. What kind of screenings should women get? How do factors like breast tissue increase the risk of breast cancer? In this episode, I'm joined by Dr. Pamela Smith, an internationally recognized functional medicine physician, author of 14 bestselling books, and co-director of the Personalized Medicine Certification at the University of South Florida.  She shares science-backed strategies to reduce your risk, strengthen your immune system, and support your body before and after a diagnosis. Things You'll Learn In This Episode  The 3 things that feed cancer Sugar, stress, and toxins are the trifecta that fuel cancer cell growth. But how do you realistically cut them out and what's secretly making them worse? Why 80% of breast cancer isn't genetic Family history matters but not as much as your environment. Which everyday exposures and habits have the biggest impact on your risk? The truth about hormones and alcohol Is hormone therapy safe? And what happens when you mix it with alcohol?  What most women don't know about screening Dense breast tissue, faulty methylation, even your gut health can affect your screening results. How do you make sure you're getting the full picture of your health?   Guest Bio Pamela Wartian Smith, M.D., MPH, MS is an internationally known speaker and author on the subject of Anti-Aging and Precision Medicine. She spent her first twenty years of practice as an emergency room physician with the Detroit Medical Center in a level 1 trauma center and then 28 years as an Anti-Aging/Functional Medicine specialist. She is a diplomat of the Board of the American Academy of Anti-Aging Physicians and is. Dr. Smith also holds a master's degree in public health and a master's degree in metabolic and nutritional medicine. She is in private practice and is the senior partner for The Center for Precision Medicine, with offices in Michigan and Florida. She has been featured on CNN, PBS, and many other television networks, has been interviewed in numerous consumer magazines, and has hosted two of her own radio shows. Dr. Smith was one of the featured physicians on the PBS series “The Embrace of Aging” as well as the online medical series “Awakening from Alzheimer's” and “Regain Your Brain”. She is the author of fourteen best-selling books, including How to Prevent Breast Cancer- Before & After: A Guide to Taking Back Control of Your Life. To learn more about Dr. Smith and to get her books, visit https://mdpamelasmith.com/.    About Your Host Hosted by Dr. Deepa Grandon, MD MBA, triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidenced-based lifestyle medicine.     ​​ Resources Feeling stuck and want guidance on how to transform your spiritual, mental and physical well being? Get access to Dr Deepa's 6 Pillars of Health video! Visit drdeepa-tlc.org to subscribe and watch the video for free. ‌ Work with Me Ready to explore a personalized wellness journey with Dr. Deepa? Visit drdeepa-tlc.org and click on “Work with Me” to schedule a free intake call. Together, we'll see if this exclusive program aligns with your needs!  Want to receive a devotional every week From Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit https://www.drdeepa-tlc.org/devotional-opt-in to subscribe for free. Ready to deepen your understanding of trauma and kick start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.   ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced. Check out this episode on our website, Apple Podcasts, or Spotify, and don't forget to leave a review if you like what you heard. Your review feeds the algorithm so our show reaches more people. Thank you!

J.J. and Dr. David Novak hike through the forest of Natural Law, and stop to examine some (Jewish) trees therein. Follow us on Bluesky @jewishideaspod.bsky.social for updates and insights!Please rate and review the the show in the podcast app of your choice.We welcome all complaints and compliments at podcasts@torahinmotion.org  For more information visit torahinmotion.org/podcastsDavid Novak is a Jewish theologian, ethicist, and scholar of Jewish philosophy and law. He is an ordained Conservative rabbi and is Professor Emeritus and J. Richard and Dorothy Shiff Chair of Jewish Studies Emeritus at the University of Toronto. David Novak is a Fellow of the Royal Society of Canada (FRSC), and a Fellow of the American Academy for Jewish Research. David Novak is to date the author of nineteen books. His book Covenantal Rights (Princeton University Press) won the American Academy of Religion Award for “best book in constructive religious thought in 2000.” He has edited four books and authored over three hundred articles and reviews in numerous scholarly and intellectual journals. He is one of the four co-authors of Dabru Emet: A Jewish Statement on Christians and Christianity.

Welcome to the Pinkleton Pull-Aside Podcast. On this podcast, let's step aside from our busy lives to have fun, fascinating life giving conversation with inspiring authors, pastors, sports personalities and other influencers, leaders and followers. Sit back, grab some coffee, or head down the road and let's get the good and the gold from today's guest. Our host is Jeff Pinkleton, Executive Director of the Gathering of the Miami Valley, where their mission is to connect men to men, and men to God. You can reach Jeff at GatheringMV.org or find him on Facebook at The Gathering of the Miami Valley.Karen Abercrombie is an award-winning actress, singer-songwriter, master oral storyteller, writer and producer. She is also an activist and an avid environmentalist. Born and raised in Aliquippa, PA, Karen is a graduate of The American Academy of Dramatic Arts in New York City. Karen has a long list of credits to her name which include playing Grandma Quill in the Marvel Franchise's, The Guardians of The Galaxy Volume 3, Judge Eleanor Thomas in the Sony Provident TV Series – Eleanor's Bench, Miss Virginia in OWN's TV Series – Delilah, and Miss Clara in the Kendrick Brothers film, War Room. You may have also seen her on Vampire Diaries, Saved by The Bell, Judging Amy, The Inspectors, Ali McBeal, Strong Medicine, etc. As for stage, Karen has appeared in numerous Off-Broadway productions. Some of her favorite stage experiences include portraying Aunt Ester in August Wilson's Gem of The Ocean at The Actors Theatre, Three Views of Mt Fuji at Playwrights Horizon, portraying Peggy in Charles Randoph Wright's Blue at The Actors Theatre, and Tambourines to Glory at The Billie Holiday Theatre. 

Brilliance without emotional control is often a recipe for destruction. In this episode, Ryan sits down with Pulitzer Prize-winning biographer Ron Chernow, whose acclaimed biographies on Alexander Hamilton, George Washington, Ulysses S. Grant, John D. Rockefeller, and most recently, Mark Twain have reshaped our understanding of American greatness. Ron and Ryan talk about how these men's deepest personal struggles and their ability to manage emotion became the defining factor in their lives and legacies.Ron Chernow is the prizewinning author of seven previous books and the recipient of the 2015 National Humanities Medal. His first book, The House of Morgan, won the National Book Award, Washington: A Life won the Pulitzer Prize for Biography, and Alexander Hamilton—the inspiration for the Broadway musical—won the George Washington Book Prize. He has twice been a finalist for the National Book Critics Circle Award and is one of only three living biographers to have won the Gold Medal for Biography of the American Academy of Arts and Letters. Ron's latest book is on the fascinating and complex life of American writer Mark Twain. Follow Ron on Instagram: @RonChernow

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 1 The discussion covered the following topics: his involvement at Rusk in patient care, research, and professional organizations; impact of COVID on Rusk; traumatic brain injury biomarkers; and recruitment and retention of health professionals.      

Major Jackson is a poet, author, and professor who is the recipient of fellowships from Guggenheim Foundation, National Endowment for the Arts, Academy of American Poets, Fine Arts works Center in Provincetown, and the Radcliffe Institute for Advanced Study at Harvard, he has been honored by the Pew Fellowship in the Arts, and the Witter Bynner foundation in conjunction with the Library of Congress, awarded the Pushcart Prize, has been published in American Poetry Review, the New Yorker, Paris Review, Orion Magazine, is an elected member of the American Academy of Arts and Sciences and serves as the Poetry Editor of The Harvard Review, and is the Gertrude Conaway Vanderbilt Chair in the Humanities and Director of Creative Writing at Vanderbilt University. We touch on stewardship, curiosity being emblematic of being human, art in a time of upheaval, human expression, AI, art monsters, and a whole lot more.Get more access and support this show by subscribing to our Patreon, right here.Links:Major JacksonEp 96 - Maggie SmithParnassusPeabody InstituteRobert FrostPhiladelphia Museum of ArtMarcel Duchamp“A Love Supreme”Ezra Klein & Rebecca Winthrop - ‘Rethinking Education'Humanities TennesseeMichaela Anne - “Is This What Mama Meant?”Hunter S ThompsonMichael RuhlmanClick here to watch this conversation on YouTube.Social Media:The Other 22 Hours InstagramThe Other 22 Hours TikTokMichaela Anne InstagramAaron Shafer-Haiss InstagramAll music written, performed, and produced by Aaron Shafer-Haiss. Become a subscribing member on our Patreon to gain more inside access including exclusive content, workshops, the chance to have your questions answered by our upcoming guests, and more.

Idiopathic intracranial hypertension (IIH) is characterized by symptoms and signs of unexplained elevated intracranial pressure (ICP) in an alert and awake patient. The condition has potentially devastating effects on vision, headache burden, increased cardiovascular disease risk, sleep disturbance, and depression.  In this episode, Teshamae Monteith, MD, FAAN speaks with Aileen A. Antonio, MD, FAAN, author of the article “Clinical Features and Diagnosis of Idiopathic Intracranial Hypertension” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Antonio is an associate program director of the Hauenstein Neurosciences Residency Program at Trinity Health Grand Rapids and an assistant clinical professor at the Michigan State University College of Osteopathic Medicine in Lansang, Michigan. Additional Resources Read the article: Clinical Features and Diagnosis of Idiopathic Intracranial Hypertension Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Guest: @aiee_antonio Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Monteith: Hi, this is Dr Teshamae Monteith. Today I'm interviewing Dr Aileen Antonio about her article on clinical features and diagnosis of idiopathic intracranial hypertension, which appears in the June 2025 Continuum issue on disorders of CSF dynamics.  Hi, how are you? Dr Antonio: Hi, good afternoon. Dr Monteith: Thank you for being on the podcast. Dr Antonio: Thank you for inviting me, and it's such an honor to write for the Continuum. Dr Monteith: So why don't you start off with introducing yourself? Dr Antonio: So as mentioned, I'm Aileen Antonio. I am a neuro-ophthalmologist, dually trained in both ophthalmology and neurology. I'm practicing in Grand Rapids, Michigan Trinity Health, and I'm also the associate program director for our neurology residency program. Dr Monteith: So, it sounds like the residents get a lot of neuro-ophthalmology by chance in your curriculum. Dr Antonio: For sure. They do get fed that a lot. Dr Monteith: So why don't you tell me what the objective of your article was? Dr Antonio: Yes. So idiopathic intracranial hypertension, or IIH, is a condition where there's increased intracranial pressure, but without an obvious cause. And with this article, we want our readers---and our listeners right now---to recognize that the typical symptoms and learning about the IIH diagnostic criteria are key to avoiding errors, overdiagnosis, or sometimes even misdiagnosis or underdiagnosis. Thus, we help make the most of our healthcare resources. Early diagnosis and management are crucial to prevent disability from intractable headaches or even vision loss, and it's also important to know when to refer the patients to the appropriate specialists early on. Dr Monteith: So, it sounds like your central points are really getting that diagnosis early and managing the patients and knowing how to triage patients to reduce morbidity and complications. Is that correct? Dr Antonio: That is correct and very succinct, yes. Dr Monteith: And so, are there any more recent advances in the diagnosis of IIH? Dr Antonio: Yes. And one of the tools that we've been using is what we call the optical coherence tomography. A lot of people, neurologists, physicians, PCP, ER doctors; how many among those physicians are well-versed in doing an eye exam, looking at the optic disc? And this is a great tool because it is noninvasive, it is high resolution imaging technique that allows us to look at the optic nerve without even dilating the eye. And we can measure that retinal nerve fiber layer, or RNFL; and that helps us quantify the swelling that is visible or inherent in that optic nerve. And we can even follow that and monitor that over time. So, this gives us another way of looking at their vision and getting that insight as to how healthy is their vision still, along with the other formal visual tests that we do, including perimetry or visual field testing. And then all of these help in catching potentially early changes, early worsening, that may happen; and then we can intervene more easily. Dr Monteith: Great. So, it sounds like there's a lot of benefits to this newer technology for our patients. Dr Antonio: That is correct. Dr Monteith: So, I read in the article about the increased incidence of IIH, and I have to say that I completely agree with you because I'm seeing so much of it in my clinic, even as a headache specialist. And I had a talk with a colleague who said that the incidence of SIH and IIH are similar. And I was like, there's no way. Because I see, I can see several people with IIH just in one day. That's not uncommon. So, tell me what your thoughts are on the incidence, the rising incidence of IIH; and we understand that it's the condition associated with obesity, but it sounds like you have some other underlying drivers of this problem. Dr Antonio: Yes, that is correct. So, as you mentioned, IIH tends to affect women of childbearing age with obesity. And it's interesting because as you've seen that trend, we see more of these IIH cases recently, which seem to correlate with that rising rate of obesity. And the other thing, too, is that this trend can readily add to the burden of managing IIH, because not only are we dealing with the headaches or the potential loss of vision, but also it adds to the burden of healthcare costs because of the other potential comorbidities that may come with it, like cardiovascular risk factors, PCOS, and sleep apnea. Dr Monteith: So why don't we just talk about the diagnosis of IIH? Dr Antonio: IIH, idiopathic intracranial hypertension, is also called pseudotumor cerebri.  It's essentially a condition where a person experiences increased intracranial pressure, but without any obvious cause. And the tricky part is that the patients, they're usually fully awake and alert. So, there's no obvious tumor, brain tumor or injury that causes the increased ICP. It's really, really important to rule out other conditions that might cause these similar symptoms; again, like brain tumors or even the cerebral venous sinus thrombosis. Many patients will have headaches or visual disturbances like transient visual obscurations---we call them TVOs---or double vision or diplopia. The diplopia is usually related to a sixth nerve palsy or an abducens palsy. Some may also experience some back pain or what we call pulsatile tinnitus, which is that pulse synchronous ringing in their ears. The biggest sign that we see in the clinic would be that papilledema; and papilledema is a term that we only use, specifically use, for those optic nerve edema changes that is only associated with increased intracranial pressure. So, performing of endoscopy and good eye exam is crucial in these patients. We usually use the modified Dandy criteria to diagnose IIH. And again, I cannot emphasize too much that it's really important to rule out other secondary causes to that increased intracranial pressure. So, after that thorough neurologic and eye evaluation with neuroimaging, we do a lumbar puncture to measure the opening pressure and to analyze the cerebrospinal fluid. Dr Monteith: One thing I learned from your article, really just kind of seeing all of the symptoms that you mentioned, the radicular pain, but also- and I think I've seen some papers on this, the cognitive dysfunction associated with IIH. So, it's a broader symptom complex I think than people realize. Dr Antonio: That is correct. Dr Monteith: So, you mentioned TVOs. Tell me, you know, if I was a patient, how would you try and elicit that from me? Dr Antonio: So, I would usually just ask the patient, while you're sitting down just watching TV---some of my patients are even driving as this happens---they would suddenly have these episodes of blacking out of vision, graying out of vision, vision loss, or blurred vision that would just happen, from seconds to less than a minute, usually. And they can happen in one eye or the other eye or both eyes, and even multiple times a day. I had a patient, it was happening 50 times a day for her. It's important to note that there is no pain associated with it most of the time. The other thing too is that it's different from the aura that patients with migraines would have, because those auras are usually scintillating and would have what we call the positive phenomena: the flashing lights, the iridescence, and even the fortification that they see in their vision. So definitely TVOs are not the migraine auras. Sometimes the TVOs can also be triggered by sudden changes in head positions or even a change in posture, like standing up quickly. The difference, though, between that and, like, the graying out of vision or the tunneling vision associated with orthostatic hypotension, is that the orthostatic hypotension would also have that feeling of lightheadedness and dizziness that would come with it. Dr Monteith: Great. So, if someone feels lightheaded, less likely to be a TVO if they're bending down and they have that grain of vision. Dr Antonio: That is correct. Dr Monteith: Definitely see patients like that in clinic. And if they have fluoride IIH, I'm like, I'll call it a TVO; if they don't, I'm like, it's probably more likely to be dizziness-related. And then we also have patient migraines that have blurriness that's nonspecific, not necessarily associated with aura. But I think in those patients, it's usually not seconds long, it's usually probably longer episodes of blurriness. Would you agree there, or…? Dr Antonio: I would agree there, and usually the visual aura would precede the headache that is very characteristic of their migraine, very stereotypical for their migraines. And then it would dissipate slowly over time as well. With TVOs, they're brisk and would not last, usually, more than a minute. Dr Monteith: So, why don't we talk about routine imaging? Obviously, ordering an MRI, and I read also getting an MRV is important. Dr Antonio: It is very important because, one: I would say IIH is also a diagnosis of exclusion. We need to make sure that the increased ICP is not because of a brain tumor or not because of cerebral venous sinus thrombosis. So, it's important to get the MRI of the brain as well as the MRV of the head. Dr Monteith: Do you do that for all patients' MRV, and how often do you add on an orbital study? Dr Antonio: I usually do not add on an orbital study because it's not really going to change my management at that point. I really get that MRI of the brain. Now the MRV, for most of my patients, I would order it already just because the population that I see, I don't want to lose them. And sometimes it's that follow-up, and that is the difficult part; and it's an easy add on to the study that I'm going to order. Again, it depends with the patient population that you have as well, and of course the other symptoms that may come with it. Dr Monteith: So, why don't we talk a little bit about CSF reading and how these set values, because we get people that have readings of 250 millimeters of water quite frequently and very nonspecific, questionable IIH. And so, talk to me about the set value. Dr Antonio: Right. So, the modified Dandy criteria has shown that, again, we consider intracranial pressure to be elevated for adults if it's above 250 millimeters water; and then for kids if it's above 280 millimeters of water. Knowing that these are taken in the left lateral decubitus position, and assuming also that the patients were awake and not sedated during the measurement of the CSF pressure. The important thing to know about that is, sometimes when we get LPs under fluoroscopy or under sedation, then these can cause false elevation because of the hypercapnia that elevated carbon dioxide, and then the hypoventilation that happens when a patient is under sedation. Dr Monteith: You know, sometimes you see people with opening pressures a little bit higher than 25 and they're asymptomatic. Well, the problem with these opening pressure values is that they can vary somewhat even across the day. People around 25, you can be normal, have no symptoms, and have opening pressure around 25- or 250; and so, I'm just asking about your approach to the CSF values. Dr Antonio: So again, at the end of the day, what's important is putting everything together. It's the gestalt of how we look at the patient. I actually had an attending tell me that there is no patient that read the medical textbook. So, the, the important thing, again, is putting everything together. And what I've also seen is that some patients would tell me, oh, I had an opening pressure of 50. Does that mean I'm in a dire situation? And they're so worried and they just attach to numbers. And for me, what's important would be, what are your symptoms? Is your headache, right, really bad, intractable? Number two: are you losing vision, or are you at that cusp where your optic nerve swelling or papilledema is so severe that it may soon lead to vision loss? So, putting all of these together and then getting the neuroimaging, getting the LP. I tell my residents it's like icing on the cake. We know already what we're dealing with, but then when we get that confirmation of that number… and sometimes it's borderline, but this is the art of neurology. This is the art of medicine and putting everything together and making sure that we care and manage it accordingly. Dr Monteith: Let's talk a little bit about IIH without papilledema. Dr Antonio: So, let's backtrack. So, when a patient will fit most of the modified Dandy criteria for IIH, but they don't have the papilledema or they don't have abducens palsy, the diagnosis then becomes tricky. And in these kinds of cases, Dr Friedman and her colleagues, when they did research on this, suggested that we might consider the diagnosis of IIH. And she calls this idiopathic intracranial hypertension without papilledema, IIHWOP. They say that if they meet the other criteria for modified Dandy but show at least three typical findings on MRI---so that flattening of the posterior globe, the tortuosity of the optic nerves, the empty sella or the partially empty sella, and even the narrowing of the transverse venous sinuses---so if you have three of these, then potentially you can call these cases as idiopathic intracranial hypertension without papilledema. Dr Monteith: Plus, the opening pressure elevation. I think that's key, right? Getting that as well. Dr Antonio: Yes. Sometimes IIHWOP may still be a gray area. It's a debate even among neuro-ophthalmologists, and I bet even among the headache specialists. Dr Monteith: Well, I know that I've had some of these conversations, and it's clear that people think this is very much overdiagnosed. So, that's why I wanted to plug in the LP with that as well. Dr Antonio: Right. And again, we have not seen yet whether is, this a spectrum, right? Of that same disease just manifesting differently, or are they just sharing a same pathway and then diverging? But what I want to emphasize also is that the treatment trials that we've had for IIH do not include IIHWOP patients. Dr Monteith: That is an important one. So why don't you wrap this up and tell our listeners what you want them to know? Now's the time. Dr Antonio: So, the- again, with IIH, with idiopathic intracranial hypertension, what is important is that we diagnose these patients early. And I think that some of the issues that come into play in dealing with these patients with IIH is that, one: we may have anchoring bias. Just because we see a female with obesity, of reproductive age, with intractable headaches, it does not always mean that what we're dealing with is IIH. The other thing, too, is that your tools are already available to you in your clinic in diagnosing IIH, short of the opening pressure when you get the lumbar puncture. And I need to emphasize the importance of doing your own fundoscopy and looking for that papilledema in these patients who present to you with intractable headaches or abducens palsy. What I want people to remember is that idiopathic intracranial hypertension is not optic nerve sheath distension. So, these are the stuff that you see on neuroimaging incidentally, not because you sent them, because they have papilledema, or because they have new headaches and other symptoms like that. And the important thing is doing your exam and looking at your patients. Dr Monteith: Today, I've been interviewing Dr Aileen Antonio about her article on clinical features and diagnosis of idiopathic intracranial hypertension, which appears in the most recent issue of Continuum on disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Thank you again. Dr Antonio: Thank you. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this CME podcast episode, Dr. Andrew Cutler interviews Dr. Phillip Coffin, Director of the Center on Substance Use and Health in San Francisco, CA, about the management of stimulant use disorders. They explore the challenges of treatment and highlight the importance of harm reduction strategies to enhance patients' quality of life.  CME credit is available to NEI Members only.   Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Summarize pharmacologic and behavioral treatment strategies for stimulant use disorders, particularly methamphetamine and cocaine Evaluate the evidence base for current and investigational medications used in clinical trials and real-world settings Apply harm reduction principles and integrated care models to improve outcomes for patients with stimulant use disorders in diverse clinical settings Accreditation: In support of improving patient care, this activity has been planned and implemented by HMP Education and Neuroscience Education Institute (NEI). HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.   Activity Overview: This activity is available with synchronized audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit.   Estimated Time to Complete: 1 hour Released: June 18, 2025*   Expiration: June 17, 2028 *NEI and HMP Education maintain a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD25-02.  Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ HMP Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse: ANCC contact hours This continuing nursing education activity awards 1.00 contact hour. Provider approved by the California Board of Registered Nursing, Provider #18006 for 1.00 contact hour. Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.00 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.00 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI and HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and are unable to report your claimed credit after this 60-day period. Ensure your profile includes your DOB and NABP ID. Physician Associate/Assistant: AAPA Category 1 CME credits HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.00 AAPA Category 1 credit. Approval is valid until June 17, 2028. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. This activity awards 1.00 CE Credit. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, HMP Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1.00 general continuing education credit. Non-Physician Member of the Healthcare Team: Certificate of Participation HMP Education awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit™) to a participant who successfully completes this educational activity. Peer Review: The content was peer-reviewed by an MD, LFAPA specializing in psychiatry, forensic, addiction to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI and HMP Education takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Any relevant financial relationships were mitigated prior to the activity being planned, developed, or presented. Disclosures are from the original live presentation, unless otherwise noted. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Phillip Coffin, MD, MIA Director of Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA No financial relationships to disclose. The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI and HMP Education planners and staff include Gabriela Alarcón, PhD, Ali Holladay, Andrea Zimmerman, EdD, CHCP, Brielle Calleo, Stephen Daniels and Bahgwan Bahroo, MD, LFAPA. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported solely by the provider, NEI.

This Week on The Virtual Curbside: Containing Measles – What Works and What Doesn't In this episode, we focus on containing the spread of measles—what pediatricians need to know about effective infection control, public health coordination, and common missteps. Host Dr. Paul Wirkus and Andy Pavia, MD along with TW Jones, MD, and Mary Fortini, DO also tackle the misunderstood role of Vitamin A in measles treatment, dispelling myths and clarifying where it fits (and doesn't) in clinical practice.Have a question? Email questions@vcurb.com. Your questions will be answered next week.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In this episode, Dr. Joy Kong sits down with hormone and integrative medicine specialist Dr. Sara Amirmehrabi of Chara Health to uncover what most doctors overlook: that many modern women's struggles with mood, memory, weight gain, and intimacy may be rooted in hormone imbalances—not just lifestyle or aging.As part of the Chara Health team, Dr. Sara Amir brings her functional, root-cause approach to hormone replacement therapy, helping patients reclaim energy, joy, and clarity. She and Dr. Joy dive deep into the latest science on perimenopause, estrogen receptors in the brain, and why a tailored HRT protocol can be life-changing for women at any age.Whether you're in your 30s and feeling off or postmenopausal and afraid to try hormones again, this episode offers science-backed hope. You'll also learn how regenerative medicine like stem cells and peptides can enhance and amplify the effects of hormone therapy—creating a true foundation for anti-aging and vitality.If you've ever been told “everything looks normal” but you know something's not right, this conversation is for you.Additional Resources:Visit My Clinic: Chara Health

In this inspiring episode, we're exploring the powerful intersection of music and accessibility with three incredible guests: Dr. Bradley Black, a world-renowned pediatric ophthalmologist and founder of the Vision Through Music program, Makayla, a passionate young musician and student in the program, and Maykaya's mother Joann.  Dr. Bradley Black (he/him) practiced pediatric ophthalmology and strabismus in Baton Rouge, Louisiana. He is past president of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) and the Louisiana Academy of Eye Physicians and Surgeons (LAEPS). He has served on the boards of directors of AAPOS, the Children's Eye Foundation, the Smith-Kettlewell Eye Research Institute, and LAEPS. He received the Honor Award, Senior Honor Award, and the Lifetime Achievement Award from AAPOS and the Achievement Award, Secretariat Award, and the Outstanding Advocate Award from the American Academy of Ophthalmology. He was elected to the American Ophthalmological Society. In 2024, he received the Parks Silver Medal, the highest honor awarded by AAPOS and CEF-AAPOS. Dr. Black is active in international ophthalmology. He served on the Orbis International Cybersight Medical Advisory Board and has performed and taught pediatric eye surgery in more than thirty countries.  One of his greatest professional achievements to date is founding the Vision Through Music program of the Children's Eye Foundation, which seeks to increase the number of music teachers who work with blind and partially sighted children nationwide. He and his wife, Cindy, have two children and two grandchildren. In his leisure time, you can often find Dr. Black sailing the Gulf of Mexico on his thirty-five-foot sloop.   Makayla Alger (she/her) is a passionate student of the Children's Eye Foundation's Vision Through Music Program (VTM). From an early age, she found joy in singing and playing on her sister's keyboard. She is currently learning violin and will soon begin voice lessons through the VTM program. Makayla lives with a mutation to the TUBB4B gene, which has led to degenerative vision and bilateral sensorineural hearing loss. Over time, she has lost night vision, experienced a decrease in peripheral vision, and developed nystagmus. Her mother, Joann, vividly remembers taking Makayla to a pediatric ophthalmologist, who determined she would need glasses for life. Initially overwhelmed and unsure whether her young daughter would keep them on, Joann recalls when Makayla looked up at her parents and with a soft voice appreciatively said, “thank you.” From that moment, she never took her glasses off. Joann says the family has gotten creative to make things more accessible at home. Beyond her love of music, Makayla is also the author of “The Way I See It”, a story following Elena, a visually and hearing-impaired red fox who navigates Vermont's scenic trails using her heightened senses. Along her journey, Elena meets many woodland creatures and teaches them important lessons about awareness, kindness, and understanding. Makayla and her mom Joann hope to raise awareness about TUBB4B genetic testing, as well as encourage more research into its progression and ultimately a cure. Whether you're a parent, educator, healthcare provider, or music lover, this conversation will show you just how transformative inclusive programming can be. Mentioned in this episode: Vision Through Music program: VisionThroughMusic.org or email contact@visionthroughmusic.org Academy of Music for the Blind: ouramb.org Makayla's book, The Way I See It available here on Amazon. Girl Scouts of America: GirlScouts.org  Summer Camp IN-SIGHT: in-sight.org/camp Stay tuned for the next new episode of “It Happened To Me”! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    “It Happened To Me” is created and hosted by Cathy Gildenhorn and Beth Glassman. DNA Today's Kira Dineen is our executive producer and marketing lead. Amanda Andreoli is our associate producer. Ashlyn Enokian is our graphic designer.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com.   

In Part 1 of our discussion on Homer's Iliad, we welcome translator Emily Wilson to discuss Homer's life as an "author," the meaning of free will in the context of intervention from gods, and how the relationship between Achilles and Patroclus shapes the climax of the epic. Emily Wilson is a professor of classical studies at the University of Pennsylvania. She has been named a Fellow of the American Academy in Rome in Renaissance and early modern studies, a MacArthur Fellow, and a Guggenheim Fellow. In addition to Homer's Iliad and Odyssey, she has also published translations of Sophocles, Euripides, and Seneca. She lives in Philadelphia.To learn more or purchase a copy of the Norton Library edition of The Iliad, go to https://wwnorton.com/books/9781324102076.  Learn more about the Norton Library series at https://wwnorton.com/norton-library.Have questions or suggestions for the podcast? Email us at nortonlibrary@wwnorton.com or find us on Twitter at @TNL_WWN and Bluesky at @nortonlibrary.bsky.social. 

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Odkaz na celý díl⁠Setkání dvou novinářských dinosaurů, přičemž každý je populární v opačné bublině. Petr Kolář je zástupce šéfredaktora v MF DNES, Václav Dolejší píše pro Seznam Zprávy a moderuje podcast Vlevo dole.Chýlí se BTC kauza ke konci? Jsou výrazněji zapojení další členové vlády? Roste nespokojenost konzervativních poslanců hnutí STAN? Petr Kolář spekuluje, že únik se do médií dostala, protože vládní špičky ignorovaly informace od tajných služeb. Václav Dolejší upozorňuje, že kauza může být důvodem povolebního rozpadu koalice SPOLU i s ohledem na tradičně silné lidovecké kandidáty v preferenčních hlasech.Partnerem podcastu je advokátní kancelář ROWAN LEGAL a provozovatel zdravotnických zařízení PENTA HOSPITALS, American Academy a ARETE Transition Fund pro kvalifikované investory.

Paul W. Werth, How Russia Got Big: A Territorial History (Bloomsbury, 2025) “Even people who know little about Russia know that it is big.” Thus Paul Werth begins his forthcoming book, How Russia Got Big: A Territorial History. The geographical expanse of the Russian Empire—known since the eighteenth century to span 1/6 of the earth—has been widely marveled upon. Scholars have explained Russia's size variously: an urge to the sea; a search for natural borders in landscapes lacking them; entrepreneurial happenstance; an insatiable hunger for conquest and more territory; a special world-historical mission. Explanations and answers, especially given Russia's invasion of its sovereign neighbor, Ukraine, are highly charged. In this small book on a big topic, Werth assembles a rivetingly concise account of what constituted the territory of Muscovy, the Russian Empire, the Soviet Union, and the Russian Federation when. The result is a startlingly refreshing synthesis that sets him up to consider the deeper ‘hows' and ‘whys' of Russian expansion and longevity. Among multiple constructive insights, Werth's analysis lays bare numerous ways in which sovereignty can be more gray than black and white—thought-provoking circumstances he frames as ‘Russia Beyond' and ‘Russia Within'. Listen in on this conversation where we talk about this book slated for release in September 2025. Paul Werth is professor of History at University of Nevada-Las Vegas. In addition to the forthcoming How Russia Got Big, he is the author of four monographs, numerous scholarly articles, and two edited volumes on Imperial Russian history, as well as a textbook. He served as the editor of the journal Kritika: Explorations in Russian and Eurasian Studies for many years. In 2022 he was named a Fellow of the John Simon Guggenheim Memorial Foundation. In the Spring of 2023 he was the Gerhard Casper Fellow at the American Academy in Berlin, and in Spring of 2024, a fellow at the Swedish Collegium for Advanced Studies in Uppsala. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/russian-studies

Join Elevated GP: www.theelevatedgp.com Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Margeas was recently named on the 2024 "32 Most Influential People in Dentistry" by Incisal Edge Magazine. Click here to learn more! Dr. Margeas graduated from the University of Iowa College of Dentistry in 1986 and completed his AEGD residency the following year. He is currently an adjunct professor in the department of Operative Dentistry at the University of Iowa. He is Board Certified by the American Board of Operative Dentistry. He is a Diplomate of the American Board of Aesthetic Dentistry, a Fellow of the Academy of General Dentistry, American Society for Dental Aesthetics and International Team of Oral implantologists (ITI). He has written numerous articles on esthetic and implant dentistry, and lectures and presents hands-on courses nationally and internationally on those subjects. He is currently the Editor in Chief of Inside Dentistry, on the Editorial Board of Compendium, and is a contributing editor to Oral Health in Canada. His memberships include OKU Honor Dental Society, American Academy of Esthetic Dentistry, and the American Academy of Restorative Dentistry. Dr. Margeas maintains a full-time private practice focusing on comprehensive restorative and implant dentistry in Des Moines, Iowa.

Discover what's possible when different brains come together.  Dr. Temple Grandin is well known for both her pioneer work as an autism advocate and her lifelong dedication to animal welfare. Through groundbreaking research aimed at understanding her own autistic mind, Dr. Grandin propelled the awareness of autism during a time when very little was known of it. She is an incredible source of hope for children with autism, their parents, and anyone with a dream.  Dr. Grandin became an internationally recognized leader in animal handling innovations after developing a corral that improved the quality of life of cattle by reducing stress. She has consulted with the USDA and major corporations such as McDonald's, Wendy's, Burger King, Whole Foods, and Chipotle. Today, half of the cattle in North America are handled in facilities she designed.  Dr. Grandin is also a prominent author, having written several books on autism and animal behavior. She has been featured on various media outlets and programs, including NPR, BBC, Larry King Live, 2020, Sixty Minutes, and TED, to name a few. In 2010, HBO produced an Emmy Award-winning movie about her life, and later that year, she was highlighted in TIME magazine's 100 Most Influential People in the World. In 2016, she was inducted into the American Academy of Arts and Sciences. These days, Dr. Grandin continues to write and teaches Animal Science at Colorado State University.  In this episode, we discuss: The spectrum of autism needs The evolution of diagnostic criteria  Dr. Grandin's opinion on the removal of Asperger's syndrome from the DSM-5 and the classification of autism under a single umbrella The neurodiversity movement ABA therapy Teaching autism awareness in schools Mental health challenges faced by autistic individuals Tips for autistic self-advocates, encouraging targeted advocacy and constructive action to make a difference in their communities For more information about Dr. Grandin and her work, please visit:  https://www.templegrandin.com/   https://www.grandin.com/ ----more---- This conversation with Dr. Temple Grandin was originally released on December 10, 2020.  Dr. Grandin's most recent book Autism and Education: The Way I See It: What Parents and Teachers Need to Know was published in April 2023. ----more---- We appreciate your time. If you enjoy this podcast and you'd like to support our mission, please take just a few seconds to share it with one person who you think will find value in it too. Follow us on Instagram: @autismpodcast Join our community on Mighty Networks: Global Autism Community Subscribe to our YouTube channel: Global Autism Project We would love to hear your feedback about the show. Please fill out this short survey to let us know your thoughts: Listener Survey

Dr. Sohini Sarah Pillai (she/her/hers) is Assistant Professor of Religion, Director of Film and Media Studies, and the Marlene Crandell Francis Endowed Chair in the Humanities at Kalamazoo College. Her research interests include Hindu traditions, epic narratives, Indian cinema, and women in religion. She is the author of Krishna's Mahabharatas: Devotional Retellings of an Epic Narrative(Oxford University Press, 2024) and the co-editor with Nell Shapiro Hawley of Many Mahabharatas(SUNY Press, 2021). Ongoing projects include a co-authored sourcebook with Emilia Bachrach and Jennifer D. Ortegren entitled Women in Hindu Traditions (NYU Press) and a monograph about cinematic adaptations of the Mahabharata and the Ramayana. She is also co-chair of the American Academy of Religion's Hinduism Unit and on the editorial board for Reading Religion. Visit Sacred Writes: https://www.sacred-writes.org/2025-carpenter-cohorts-spring-semester  

In this episode of Health Matters, we discuss what causes dizziness with Dr. Louise Klebanoff, a neurologist with NewYork-Presbyterian and Weill Cornell Medicine. Dr. Klebanoff explains the different types of dizziness, such as lightheadedness, vertigo, and gait instability. We also cover how to differentiate between these types, the potential causes, and  when to seek medical attention.___Dr. Louise Klebanoff, MD has been named the Chief of General Neurology and the Vice Chair of Operations for the Department of Neurology at Weill Cornell Medical College. She is also an Assistant Attending Neurologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.  Dr. Klebanoff received her medical degree from Georgetown University Medical Center, graduating first in her class, and went on to complete a residency in Neurology and a fellowship in Critical Care Neurology at NewYork-Presbyterian Hospital/Columbia University Medical Center.Prior to joining the Weill Cornell faculty, Dr. Klebanoff served as Attending Neurologist at Beth Israel Medical Center, where she also held leadership roles on various committees and served as the first female president of the Medical Board.Dr. Klebanoff is board certified in Psychiatry and Neurology. She is a member of the Alpha Omega Alpha honor society, the American Medical Association and the American Academy of Neurology.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

Host Mikalyn DeFoor, MD Guest interviewee Annunziato Amendola, MD, FAAOS, AAOS President 2025-2026, discussing his presidential address, “Moving Forward” from the June 15, 2025 issue Article summarized from the June 1, 2025 issue Research article “Physician-Led Orthopaedic Hospitals Outperform Nonphysician-Led Orthopaedic Hospitals: An Analysis of the Top 200 Orthopaedic Hospitals” Article summarized from the June 15, 2025 issue Review article “Workplace Violence in Health Care: Current State of Affairs and Methods of Prevention” See also the AAOS Webinar in Workplace Violence in Health Care: Current State of Affairs and Methods of Prevention – Monday, July 14, 2025, 7:15-8:15 pm CST To register, go here. Follow this link to download these and other articles from the June 1, 2025 issue of JAAOS and the June 15, 2025 issue of JAAOS. The JAAOS Unplugged podcast series is brought to you by the Journal of the American Academy of Orthopaedic Surgeons and the AAOS Resident Assembly.

In this episode, we go beyond the clinical basics to explore the history of measles, common complications, and current approaches to diagnosis and management. Our guests also tackle the rise in misinformation and share strategies for having effective, empathetic conversations with families about measles and the MMR vaccine. Listen to the fascinating discussion with host Dr. Paul Wirkus, who is joined by TW Jones, MD, Andy Pavia, MD, and Mary Fortini, DO.Have a question? Email questions@vcurb.com. Your questions will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This episode packs an impactful punch and is a can't-miss! Host Dr. Vin Gupta is joined by recently declared U.S. Senate candidate Dr. Annie Andrews, who is looking to unseat Lindsey Graham in 2026, for an expansive discussion on her candidacy, policy priorities, and broader calls to action. Afterwards, Dr. Sean O'Leary, Professor of Pediatrics and Chair of the Committee on Infectious Diseases at the American Academy of Pediatrics, provides much-needed clarity on the chaotic messaging about childhood vaccines that came out of HHS last week. Learn more about your ad choices. Visit megaphone.fm/adchoices

Rheumatoid arthritis, lupus, and Crohn’s disease are autoimmune diseases that share a lot of commonalities. This episode covers when and how they were first recognized and described. Research: Aceves-Avila, Francisco Javier et al. “The Antiquity of Rheumatoid Arthritis: A Reappraisal.” The Journal of Rheumatology 2001; 28:4. Arnaud, Laurent et al. “The History of Lupus Throughout the Ages.” Journal of the American Academy of Dermatology. Volume 87, Issue 6, December 2022. https://www.sciencedirect.com/science/article/abs/pii/S0190962220307726 Barber, Megan R W et al. “Global epidemiology of systemic lupus erythematosus.” Nature reviews. Rheumatology vol. 17,9 (2021): 515-532. doi:10.1038/s41584-021-00668-1 Bornstein, Joseph E. and Randolph M. Steinhagen. “History of Crohn’s Disease.” From Crohn’s Disease: Basic Principles. Springer. 2015. Crohn & Colitis Foundation. “IBD before the Foundation.” https://www.crohnscolitisfoundation.org/about/our-beginning Entezami, Pouya et al. “Historical perspective on the etiology of rheumatoid arthritis.” Hand clinics vol. 27,1 (2011): 1-10. doi:10.1016/j.hcl.2010.09. Geller, Stephen A. and Fernando P F de Camposc. “Crohn disease.” Autopsy Case Rep [Internet]. 2015; 5(2):5-8. http://dx.doi.org/10.4322/acr.2015.001 Hyndman, I.J. (2017), Rheumatoid arthritis: past, present and future approaches to treating the disease. Int J Rheum Dis, 20: 417-419. https://doi.org/10.1111/1756-185X.12823 Kirsner, J B. “Historical origins of current IBD concepts.” World journal of gastroenterology vol. 7,2 (2001): 175-84. doi:10.3748/wjg.v7.i2.175 Laberge, Monique, and Philip E. Koth. "Rheumatoid Arthritis." The Gale Encyclopedia of Medicine, edited by Jacqueline L. Longe, 6th ed., vol. 7, Gale, 2020, pp. 4474-4480. Gale In Context: Science, link.gale.com/apps/doc/CX7986601640/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=8b8ee977. Accessed 30 Apr. 2025. Laurent Arnaud - I6 The history of lupus throughout the ages: Lupus Science & Medicine 2020;7:. https://doi.org/10.1136/lupus-2020-eurolupus.6 org. “The History of Lupus.” https://www.lupus.org/resources/the-history-of-lupus Mandal, Dr. Ananya. “Rheumatoid Arthritis History.” News Medical. 7/7/2023. https://www.news-medical.net/health/Rheumatoid-Arthritis-History.aspx Medical News Today. “The History of Rheumatoid Arthritis.” 5/2/2023. https://www.medicalnewstoday.com/articles/rheumatoid-arthritis-history Michniacki, Thomas. “Crohn’s Disease: An Evolutionary History.” University of Michigan Library. 2006-05 http://hdl.handle.net/2027.42/96969 Potter, Brian. “The History of the Disease Called Lupus.” Journal of the History of Medicine and Allied Sciences , JANUARY 1993, Vol. 48, No. 1 (JANUARY 1993). Via JSTOR. http://www.jstor.com/stable/24622869 Sathiavageesan, Subrahmanian, and Suganya Rathnam. “The LE Cell-A Forgotten Entity.” Indian journal of nephrology vol. 31,1 (2021): 71-72. doi:10.4103/ijn.IJN_249_19 Scofield, R Hal, and James Oates. “The place of William Osler in the description of systemic lupus erythematosus.” The American journal of the medical sciences vol. 338,5 (2009): 409-12. doi:10.1097/MAJ.0b013e3181acbd71 "Systemic Lupus Erythematosus." National Institute of Arthritis and Musculoskeletal and Skin Diseases Pamphlets, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2001, p. 1. Gale Academic OneFile, link.gale.com/apps/doc/A79512544/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=534bac78. Accessed 30 Apr. 2025. Thomas, Donald E. et al. “The first use of “lupus” as a disease.” Lupus. 2025, Vol. 34(1) 3–9. Tish Davidson, and Rebecca J. Frey. "Crohn's Disease." The Gale Encyclopedia of Medicine, edited by Jacqueline L. Longe, 6th ed., vol. 2, Gale, 2020, pp. 1423-1427. Gale In Context: Science, link.gale.com/apps/doc/CX7986600509/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=2687d598. Accessed 30 Apr. 2025. Van Hootegem, Phillippe. “Is Crohn’s A Rightly Used Eponym?” J Crohns Colitis. 2020 Jul 9;14(6):867-871. doi: 10.1093/ecco-jcc/jjz183. See omnystudio.com/listener for privacy information.